[1]李彬 刘江文 王凤媛 文英 蒋学俊.4-辛基衣康酸减轻脂多糖诱导的心肌损伤[J].心血管病学进展,2023,(1):82-86.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.018]
　LI Bin,LIU Jiangwen,WANG Fengyuan,et al.4-Octyl Itaconate Attenuates Lipopolysaccharide-Induced Myocardial Injury[J].Advances in Cardiovascular Diseases,2023,(1):82-86.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.018]
点击复制

4-辛基衣康酸减轻脂多糖诱导的心肌损伤()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年1期
页码:
82-86
栏目:
论著
出版日期:
2023-01-25

文章信息/Info

Title:
4-Octyl Itaconate Attenuates Lipopolysaccharide-Induced Myocardial Injury
作者:
李彬 刘江文 王凤媛 文英 蒋学俊
(武汉大学人民医院心内科 武汉大学心血管病研究所 心血管病湖北省重点实验室,湖北 武汉 430060)
Author(s):
LI Bin; LIU Jiangwen; WANG Fengyuan; WEN Ying; JIANG Xuejun
(Department of Cardiology,Renmin Hospital of Wuhan University,Cardiovascular Research Institute,Wuhan University,Hubei Key Laboratory of Cardiology,Wuhan 430060,Hubei,China)
关键词:
4-辛基衣康酸; 脂多糖; 炎症; 氧化应激
Keywords:
4-Octyl itaconate; Lipopolysaccharide; Inflammation; Oxidative stress
DOI:
10.16806/j.cnki.issn.1004-3934.2023.01.018
摘要:
目的 探讨4-辛基衣康 酸（4-OI）对脂多糖（LPS）诱导的小鼠心肌损伤的影响。方法 采用6～8周雄性C57BL/6J小鼠，经腹腔注射4-OI（25 mg/kg）或等量生理盐水连续预处理3 d后，腹腔注射LPS（10 mg/kg）或等量生理盐水，12 h后行心脏超声检查。取心脏，行苏木精-伊红（HE）染色观察心肌病理变化；Western blot检测心肌组织中肿瘤坏死因子-α（TNF-α）、白介素1β（IL-1β）、p65、pp65、谷胱甘肽过氧化物酶4（GPx4）、前列腺素内过氧化物合成酶2（PTGS2）和核转录因子红系2相关因子（Nrf2）的蛋白表达水平。结果 心脏超声结果显示，LPS腹腔注射后，小鼠左心室明显扩张， 收缩功能减低；与LPS组相比，4-OI组小鼠左心室收缩功能改善。HE染色示LPS腹腔注射后，小鼠心脏炎症细胞浸润明显，心肌细胞排列疏松，表现出类似于脓毒症诱导的心肌损伤的病理特点。4-OI组小鼠心脏的炎症细胞浸润程度和病理改变较LPS组低。Western blot示LPS腹腔注射后，小鼠心肌组织中Nrf2和GPx4的表达明显降低，IL-1β、TNF-α、PTGS2以及pp65/p65表达明显升高；与LPS组相比，4-OI组小鼠心肌组织中的Nrf2和GPx4蛋白水平更高，而IL-1β、TNF-α、pp65/p65和PTGS2表达水平降低。结论 4-OI预处理可通过减轻炎症和氧化应激，减轻LPS诱导造成的心肌损伤，从而保护心脏功能。
Abstract:
Objective To investigate the effect of 4-octyl itaconate(4-OI) on lipopolysaccharides(LPS) -induced myocardial injury in mice. Methods Male C57BL/6J mice of 6 ~8 weeks were injected intraperitoneally with 4-OI(25 mg/kg) or an equivalent amount of normal saline for continuous pretreatment for 3 days. LPS(10 mg/kg) or an equivalent amount of normal saline was injected intraperitoneally,and echocardiography was performed 12 hours later. The hearts were taken for hematoxylin and e osin(HE) staining to observe myocardial pathological changes;the protein expression levels of tumor necrosis factor-α(TNF-α),interleukin-1β(IL-1β),p65,pp65,glutathione peroxidase 4(GPx4),prostaglandin endoperoxide synthase 2(PTGS2),nuclear factor erythroid 2-related factor 2(Nrf2) in myocardial tissue were detected by Western blot. Results Cardiac ultrasound results showed that the left ventricle of mice significantly expanded and the systolic function decreased after LPS intraperitoneal injection;and compared with LPS group,the left ventricular systolic function in 4-OI group was improved. HE staining showed that the inflammatory cells in the heart of mice were significantly infiltrated and the arrangement of myocardial cells was loose after intraperitoneal injection of LPS,showing pathological characteristics similar to sepsis-induced myocardial injury. The degree of inflammatory cell infiltration and pathological changes in the heart of 4-OI group was lower than that of LPS group. Western blot showed that the expression of Nrf2 and GPx4 in myocardial tissue of mice were decreased significantly after intraperitoneal injection of LPS,but the expression of IL-1β,TNF-α,PTGS2 and pp65/p65 expression were increased significantly;and compared with LPS group,Nrf2 and GPx4 protein levels in myocardial tissue of 4-OI group were higher,while the expression levels of IL-1β,TNF- α,pp65/p65 and PTGS2 were decreased. Conclusion 4-OI pretreatment can protect cardiac function by reducing inflammation and oxidative stress,reducing LPS-induced myocardial damage.

参考文献/References:

[1]Cecconi M,Evans L,Levy M,et al. Sepsis and septic shock[J]. Lancet,2018 ,392(10141):75-87.

[2]Greco E,Lupia E,Bosco O,et al. Platelets and multi-organ failure in sepsis[J]. Int J Mol Sci,2017,18(10):2200.

[3]Prescott HC,Angus DC. Enhancing recovery from sepsis:a review [J]. JAMA,2018 ,319(1):62-75.

[4]Peace CG,O’Neill LA. The role of itaconate in host defense and inflammation[J]. J Clin Invest,2022 ,132(2):e148548.

[5]Mills EL,Ryan DG,Prag HA,et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1[J]. Nature,2018,556(7699):113-117.

[6]Li R,Yang W,Yin Y,et al. Protective role of 4-octyl itaconate in murine LPS/D-GalN-induced acute liver failure via inhibiting inflammation,oxidative stress,and apoptosis[J]. Oxid Med Cell Longev,2021,2021:9932099.

[7]Settelmeier S,Rassaf T,Hendgen-Cotta UB. Revealing subtle changes in cardiac function using transthoracic dobutamine stress echocardiography in mice[J]. J Vis Exp,2021 ,168.DOI:10.3791/62019.

[8]Ge WD,Li FZ,Hu BC,et al. Factors associated with left ventricular diastolic dysfunction in patients with septic shock[J]. Eur J Med Res,2022,27(1):134.

[9]Okuhara Y,Yokoe S,Iwasaku T,et al. Interleukin-18 gene deletion protects against sepsis-induced cardiac dysfunction by inhibiting PP2A activity[J]. Int J Cardiol,2017,243:396-403.

[10]Huang Q,Liu DH,Chen CF,et al. Pgc-1α promotes phosphorylation,inflammation,and apoptosis in H9c2 cells during the early stage of lipopolysaccharide induction[J]. Inflammation,2021,44(5):1771-1781.

[11]Hanna A,Frangogiannis NG. Inflammatory cytokines and chemokines as therapeutic targets in heart failure[J]. Cardiovasc Drugs Ther,2020,34(6):849-863.

[12]Zang Q,Maass DL,Tsai SJ,et al. Cardiac mitochondrial damage and inflammation responses in sepsis[J]. Surg Infect(Larchmt),2007,8(1):41-54.

[13]Forcina GC,Dixon SJ. GPX4 at the crossroads of lipid homeostasis and ferroptosis[J]. Proteomics,2019,19(18):e1800311.

[14]Clemente SM,Martínez-Costa OH,Monsalve M,et al. Targeting lipid peroxidation for cancer treatment[J]. Molecules,2020,25(21) :5144.

相似文献/References:

[1]王猛 江洪.肠道菌群及其代谢产物与心房颤动的研究进展[J].心血管病学进展,2022,(3):214.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
　WANG Meng,JIANG Hong.Gut Microbiota an d Its Metabolites in Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(1):214.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[2]蒋振江 刘富强 王军奎.肠道菌群与肥胖的关系研究进展[J].心血管病学进展,2023,(3):265.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.017]
　JIANG Zhenjiang,LIU Fuqiang,WANG Junkui.The Relationship Between Gut Microbiota and Obesity[J].Advances in Cardiovascular Diseases,2023,(1):265.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.017]

更新日期/Last Update: 2023-03-10